BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• NLS Pharmaceutics to Participate in the Canaccord Genuity 41st Annual Growth Conference

  NLS Pharmaceutics Ltd. announces that Alex Zwyer, Chief Executive Officer and Co-Founder, is scheduled to present at the Canaccord Genuity 41 st Annual Growth Conference being held virtually August 10-12, 2021.

  August 5, 2021

   · 

  1 min read
• Business

  La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate Progress

  La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate Progress

  August 5, 2021

   · 

  15 min read
• Business

  Hillstream BioPharma and Minotaur Therapeutics Sign Term Sheet to Advance Next-Generation Targeted Knob Biologics for Undruggable Targets

  Hillstream BioPharma, Inc. today announced the signing of a non-binding term sheet with Minotaur Therapeutics (“Minotaur”) to advance the development of the next generation targeted Knob biologics for undruggable targets including c-MYC combined with Hillstream’s tumor-targeting Quatramers™.

  August 5, 2021

   · 

  5 min read
• Biotech Bay

  Bolt Threads to Leverage Ginkgo Bioworks’ Platform for Commercial Strain Optimization of b-silk™ Protein

  Bolt Threads, a biotechnology company creating the next generation of advanced materials, and Ginkgo Bioworks, Inc., which is building the leading horizontal platform for cell programming, announced a partnership.

  August 5, 2021

   · 

  9 min read
• Business

  Precision for Medicine and Trialbee Partner to Advance Clinical Trials for Complex Therapies and Speed Shift Toward Precision Medicine

  Clinical research organization Precision for Medicine and Trialbee, a patient matching and enrollment platform, are addressing complexities in clinical development through a new partnership that will accelerate the future of precision medicine.

  August 5, 2021

   · 

  4 min read
• LumiraDx Receives FDA Emergency Use Authorization for its COVID-19 Antibody Test, Now Allowing COVID-19 Antigen and Antibody Testing on a Single Point of Care Platform

  Today, LumiraDx, a next-generation point of care diagnostics testing company announced it has received FDA Emergency Use Authorization (EUA) for its SARS-CoV-2 Ab test.

  August 5, 2021

   · 

  4 min read
• Business

  Applied DNA Schedules Fiscal 2021 Third Quarter Financial Results Conference Call and Webcast for Thursday, August 12, 2021

  Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction - based DNA manufacturing and nucleic acid-based technologies, announced that it will report fiscal 2021 third quarter financial results after market close on Thursday, August 12, 2021.

  August 5, 2021

   · 

  2 min read
• Arterial Blood Gas Kits Market: Increasing Prevalence of Respiratory Diseases

  The arterial blood gas kits market is expected to reach US$ 773.01 million in 2028 from US$ 455.84 million in 2021 growing at a CAGR of 7.8% from 2021-2028.

  August 5, 2021

   · 

  3 min read
• Chiropractic Care Market – Know the Emerging Trends and Growth Opportunities across the Market

  Chiropractic therapy is a type of non-invasive therapeutics for the treatment of disorders associated with the central nervous system.

  August 5, 2021

   · 

  3 min read
• Medical Collagen Market: Innovative Competitive Strategies of Key Players Fueling Market Growth

  The report highlights trends prevailing in the global medical collagen market and factors driving the market growth.

  August 5, 2021

   · 

  3 min read